New heart mapping tech could improve AFib treatment

NCT ID NCT06529978

Recruiting now Disease control Sponsor: CoreMap Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study tests a new mapping system (CoreMap) to help doctors treat persistent atrial fibrillation (AFib), a type of irregular heartbeat. About 245 adults with persistent AFib will have a standard procedure called ablation, but with the CoreMap system guiding the treatment. The goal is to see if the system is safe and helps prevent AFib from coming back for at least 12 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation persistent atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERSISTENT ATRIAL FIBRILLATION

Contacts and locations

Locations

NCH Downtown Baker Hospital
ENROLLING_BY_INVITATION

Naples, Florida, 34102, United States
Na Homolce Hospital
RECRUITING

Praha Klanovice, Czechia
University of Vermont Medical Center
ENROLLING_BY_INVITATION

Burlington, Vermont, 05401, United States
Virginia Commonwealth University (VCU)
ENROLLING_BY_INVITATION

Richmond, Virginia, 23284, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.